👋🏽 - yes you, all in oncology interested in advancing the field! 👏🏽👏🏽👏🏽Please vote for Melvin Melvin LK CHUA | FRCR, PhD, FASCO for ASCO Board of Directors. He is an outstanding #radonc, clinician-scientist and leader. A great advocate for the field!

ASCO Election 2025: Meet the Candidates for Leadership Positions Herbert Loong, MBBS, FASCO Melvin LK CHUA | FRCR, PhD, FASCO Karyn Goodman, MD, MS Dawn Hershman Dr. Kimryn Rathmell Neeraj Agarwal, MD, FASCO Mina S. Sedrak Ana I. Velázquez Mañana, MD, MSc, FASCO ASCO oncodaily.com/insight/asco-e… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #ASCO

First time attending #AROI meeting in 🇮🇳 Super impressive how big the #RadiationOncology community is with ~5000 members! Thanks to ASCO for the invitation to this collaboration to grow collabs in the region! Indranil Mallick

Only 1 more week left for you to cast your ballot 🗳️ in this year's ASCO Board of Director's Elections! I am running as a candidate in the #DesignatedInternationalOncologist and hope to have your support! I am running alongside 12 very capable candidates - so check out more

#ESMOASIA25 Thanks to ESMO - Eur. Oncology for the support for #RadiationOncology Can’t believe it has taken me that long to invite the affable famous Shankar Siva to visit and deliver a lecture at NCCS! Thanks for sharing with us the wisdoms on #SBRT Kevin Chua Ravindran Kanesvaran

#ESMOASIA25 Thanks to ESMO - Eur. Oncology Dr Oosting for supporting #HeadNeckCancer in the programme Always fun to partner with Prof Brigette Ma to moderate #Deescalation of treatments in #HPV #OPSCC

Last few days to vote for the ASCO elections! I am humbled to be nominated for the Designated Radiation Oncologist seat. Do take a look at the other 12 highly qualified candidates! asco.org/about-asco/asc…

Super engaged #ESMOYOC session of #ESMOAsia25 with Vesalius talk about Research, Education, & Collaboration for #YoungOncologists in Asia-Pacific, fantastic discussion with our amazing international experts 🤩 Dr Bharti Devnani 🇮🇳 Mariana Brandao 🇧🇪 #StephanChan 🇭🇰 Paula Isabel G. Franco 🇵🇭

#ESMOAsia25 Packed room for #RadiationOncology session! Such a strong line up of speakers! Shankar Siva Dr Luis Jacomina Kevin Chua Alison Tree 💙

Very nice session supported by ESMO - Eur. Oncology at #ESMOAsia2025 discussing what’s hot🔥in SABR/SBRT… expertly chaired by Melvin LK CHUA | FRCR, PhD, FASCO and Alison Tree 💙, and talks by Kevin Chua luisajacomina 🤗 #radonc

Final 48 hours in the ASCO Board of Directors Election! ⏰ Echoing Shankar Siva’s earlier call — please vote for my brother Melvin LK CHUA | FRCR, PhD, FASCO as the Designated Radiation Oncologist on the Board. I’ve watched firsthand how he’s driven radiation oncology forward and elevated cancer

And last session of the day as well! Strong support from #radiationoncology community here in #ESMOAsia25 💪🏻 2nd session tomorrow at 14:15 !

#ScienceSaturday ❓ How do scientists find the immune cells that are truly fighting a tumor? ➡️ A new nature study reveals that powerful tumor-killing T cells may be hiding in plain sight, not as single cells, but in clusters attached to tumor cells or antigen-presenting

#ESMOAsia2025 So nice to see my GU brother Arun Azad And now another 🇦🇺GU brother Shankar Siva is chairing #RadiationOncology session #2 with my REAL brother Kevin Chua Kicking off - Eric Deutsch Gustave Roussy speaking on #RadioImmunotherapy Come join us!

“Navigating the Multidisciplinary Meeting (MDT)” - sharing some common wisdoms with the Young Oncologist ESMO - Eur. Oncology session last day of #ESMOAsia25

Lovely way to close out #ESMOAsia25 with my #radonc friends Melvin LK CHUA | FRCR, PhD, FASCO Eric Deutsch Kevin Chua , Dr Hong Qi Tang, Dr Ling-Long Tang ESMO - Eur. Oncology

Fantastic #radonc session to close #ESMOAsia2025! Huge thanks to Shankar Siva Eric Deutsch Dr Ling-Long Tang, Dr Hong Qi Tang & Melvin LK CHUA | FRCR, PhD, FASCO for brilliant talks on ImmunoRT, target optimization, AI & overcoming radioresistance. Till next time! 🙌

From Hongcheng Zhu 祝鸿程 and the IASLC Advanced Radiation Technology (ART) subcommittee - Practical management of 5 unresectable locally advanced NSCLC cases here ➡️ jto.org/action/showPdf… a☢️🫁🧵...

🌍 Uniting the Asia-Pacific oncology community! ESMO Asia 2025: 4,550+ participants, 170+ speakers, 71 sessions & 940+ abstracts shared. 🙌 A record-breaking milestone for oncology in Asia! #ESMOAsia25 #esmomeetings 🔗 ow.ly/ujGP50XGiq0

My goal is to bridge science with the lived experience. And in the context of oligometastatic/progressive/persistent disease, the decision is more than the mutation, the number of sites, and the locations. This is my lung cancer experience condensed in one slide (timeline credit